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ABSTRACT
The functional and structural-dynamical properties
of the Lys681Ala mutation in the human topoiso-
merase IB linker domain have been investigated
by catalytic assays and molecular dynamics simula-
tion. The mutant is characterized by a comparable
cleavage and a strongly reduced religation rate
when compared to the wild type protein. The
mutant also displays perturbed linker dynamics, as
shown by analysis of the principal components of
the motion, and a reduced electrostatic interaction
with DNA. Inspection of the inter atomic distances
in proximity of the active site shows that in the
mutant the distance between the amino group of
Lys532 side chain and the 50 OH of the scissile
phosphate is longer than the wild type enzyme,
providing an atomic explanation for the reduced
religation rate of the mutant. Taken together
these results indicate the existence of a long
range communication between the linker domain
and the active site region and points out the
crucial role of the linker in the modulation of the
catalytic activity.
INTRODUCTION
DNA topoisomerase IB catalyzes the relaxation of
supercoiled DNA through the transient cleavage of one
strand of a DNA duplex and is of fundamental impor-
tance to processes such as replication, recombination
and transcription (1–3). The enzyme is found in mono-
meric form in all eukaryotic systems (except for the
unusual bi-subunit enzyme from kinetoplastid protozoan
parasite Leishmania donovani), and its presence has been
reported also in bacteria, and viruses (4–7).
The human topoisomerase IB enzyme (Top1) is
composed of 765 amino acids and has four distinct
domains: the NH2-terminal domain (1–214), the core
domain (215–635), the linker domain (636–712) and the
COOH-terminal domain (713–765) (8–10). The three-
dimensional structure of reconstituted N-terminal
truncated versions of human Top1 in complex with a
22bp DNA molecule shows the enzyme organized in
multiple domains which ‘clamp on’ the DNA molecule
(9). Changes in DNA topology are achieved by
introducing a transient break in the phosphodiester
bond of one strand in the duplex DNA. Phosphodiester
bond energy is preserved during catalysis through the
formation of a transient covalent phosphotyrosine bond
between the catalytic Tyr723 and the 30-end of the broken
DNA strand. DNA relaxation has been proposed to
proceed via ‘controlled rotation’: the catalytic tyrosine
holds one end of the DNA duplex, and the enzyme then
accompanies the end downstream of the cleavage site to
rotate around the remaining phosphodiester bond (10).
Human Top1 is of signiﬁcant medical interest being
the only target of the antitumor agent camptothecin
(CPT). CPT reversibly binds to the covalent intermediate
DNA-enzyme, stabilizing the cleavable complex and
reducing the rate of religation. The stalled topoisomerase
I collides with the progression of the replication fork
producing lethal double strand DNA breaks and cell
death (1,11).
*To whom correspondence should be addressed. Tel: +39 0672594376; Fax: +39 0672594326; Email: desideri@uniroma2.it
The authors wish it to be known that, in their opinion, the ﬁrst two authors should be regarded as joint First Authors.
Published online 18 September 2009 Nucleic Acids Research, 2009, Vol. 37, No. 20 6849–6858
doi:10.1093/nar/gkp669
 The Author(s) 2009. Published by Oxford University Press.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/
by-nc/2.5/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.A crucial role in the catalytic mechanism is played by
the linker domain, that has been proposed to be involved
in the relaxation reaction, acting as a ‘brake’ during the
rotation of the DNA, downstream of the cleavage site
(12,13). The linker has been shown to be in direct
contact with the DNA since it is more resistant to
proteolysis when the enzyme is non-covalently bound to
duplex DNA (8) and it is one of the most ﬂexible protein
regions, as evidenced by multiple non-isomorphous crystal
structures (12). Upon removal of the linker domain the
enzyme retains its activities in vitro but passes from a
processive to a distributive DNA relaxation (13), suggest-
ing the loss of interdomain communication as also
indicated by an all atom molecular dynamics (MD) simu-
lation of the enzyme in the presence or absence of the
linker (14). Actually, it has been shown that even the
single mutation of Thr729 in Lys abolishes the protein
communications between the C-terminal and the linker
domain, altering the interactions between helix 17 in the
core domain and helix 19 in the linker domain (15,16).
Interdomain communications between the linker and
other protein domains have been recently conﬁrmed by
means of a long time scale coarse grained molecular
dynamics simulation (17), while non-equilibrium molecu-
lar dynamics simulations have identiﬁed distinct
mechanisms for positive and supercoiled DNA relaxation,
where the linker domain plays an essential role (18).
Finally, it has been reported that the linker must retain
a minimum length in order to have a fully functional
enzyme (19).
Top1 sensitivity to CPT is modulated by several
mutations (20–22), most of them are located in the prox-
imity of the active site and make the enzyme insensitive to
CPT lowering the enzyme drug binding. Interestingly, also
mutations located far away from the active site and in
particular in the linker have been found to modulate the
enzyme sensitivity toward the drug, conﬁrming the impor-
tant role played by this domain. In particular mutation of
residue 653, from Ala to Pro has been shown to render the
enzyme resistant to CPT and to confer an enhanced linker
ﬂexibility correlated to an increased religation rate that
does not permit CPT to stabilize the enzyme–DNA
covalent complex (23). Mutations of the linker domain
have been shown also to increase the CPT enzyme sensi-
tivity conﬁrming the occurrence of long range communi-
cation between the linker domain and the active site region
(24). The linker can also feel perturbations introduced in
proximity of the active site, since mutation of Thr718,
close to the active site Tyr723, induces altered linker ﬂex-
ibility (25). Evidence of a correlation between these
two regions comes also from the absence of the linker
domain electron density map in the enzyme–DNA
binary but not in the enzyme–DNA–CPT ternary
complex (20). Additional evidence for a long range com-
munication between these two domains comes from the
double mutant Ala653Pro-Thr718Ala, involving two
residues, Ala653 and Thr718, located on the linker
domain and in proximity of the active site, respectively.
The combination of the two mutations abolishes the lethal
phenotype of the single mutant Thr718Ala, demonstrating
how a mutation on the linker domain can inﬂuence the
active site region (26).
In the present work we have continued our study of the
role of linker domain, mutating the highly conserved
residue Lys681, located on the tip of the linker, in Ala.
Experimental characterization of the mutant indicates a
reduced religation rate when compared to the wild type
protein. MD simulation indicates that the linker is
characterized by a decrease in ﬂexibility correlated
with a reduced linker-DNA electrostatic interaction. The
simulation also points out an increased distance between
Lys532 and the 50 OH of the +1 base phosphate; this
makes the proton transfer needed in the religation
reaction more diﬃcult and provides an atomistic hypoth-
esis for the experimentally observed reduced religation
rate.
MATERIALS AND METHODS
Yeast strains, plasmids and chemicals
Camptothecin (Sigma) was dissolved in dimethyl sulfoxide
(Me2SO) to a ﬁnal concentration of 4mg/ml and stored
at  20 C. Anti-FLAG M2 aﬃnity gel, FLAG peptide
and M2 monoclonal antibody were purchased from
Sigma. Saccharomyces cerevisiae strain EKY3 (ura3-52,
his3D200, leu2D1, trp1D63, top1::TRP1, MAT) was
previously described (27). Plasmid YCpGAL1- wild type
was described previously (28). Lys681Ala was generated
by oligonucleotide-directed mutagenesis of the
YCpGAL1-wild type in which the human topoisomerase
I is expressed under the galactose inducible promoter
in a single-copy plasmid. The epitope-tagged construct
YCpGAL1-e-wild type contains the N-terminal sequence
FLAG: DYKDDDY (indicated with ‘e’), recognized by
the M2 monoclonal antibody. The epitope-tag was
subcloned into YCpGAL1-Lys681Ala to produce the
YCpGAL1-e-Lys681Ala construct.
Puriﬁcation of DNA topoisomerase I
Epitope tagged EKY3 cells were transformed with
YCpGAL1-e-wild type and YCpGAL1-e-Lys681Ala,
grown on SC-uracil plus 2% dextrose and diluted 1:100
in SC-uracil plus 2% raﬃnose. At an optical density A595
of 1.0, the cells were induced with 2% galactose for 6h.
Cells were then harvested by centrifugation, washed with
cold water and resuspended in 2ml buﬀer/g cells using a
buﬀer containing 50mM Tris, pH 7.4, 1mM EDTA,
1mM ethylene glycol-bis(2-aminoethylether)-N,N,N’,N’-
tetraacetic acid, 10% (v/v) glycerol completed with
protease inhibitors cocktail (Roche 1836153) and supple-
mented with 0.1mg/ml sodium bisulﬁte and 0.8mg/ml
sodium ﬂuoride. After addition of 0.5 volume of
425–600mm diameter glass beads the cells were disrupted
by vortexing for 30s alternating with 30s on ice. The
lysate was centrifuged and KCl ﬁnal concentration
0.15M was added to the sample prior to loading onto
2ml ANTI-FLAG M2 Aﬃnity Gel column equilibrated
as described in the technical bulletin (Sigma). The column
was washed with 20 column volumes of TBS (50mM Tris–
HCl, 150mM KCl, pH 7.4). Elution of FLAG-fusion
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ﬁve column volumes of a solution containing 100mg/ml
FLAG peptide in TBS. Fractions of 500ml were collected
and glycerol ﬁnal concentration 40% was added; all
preparations were stored at  20 C. The fractions were
resolved by SDS-polyacrylamide gel electrophoresis;
protein concentration and integrity were measured
through immunoblot assay, using the epitope-speciﬁc
monoclonal antibody M2. After normalization to the
same amount of protein, the activity of the wild type
and mutant DNA topoisomerase I, as assayed by relax-
ation of supercoiled DNA in 150mM KCl, was found to
be almost identical. In all experiments the same amount of
wild type and mutated protein was used.
Kinetics of cleavage using oligonucleotide substrate
Oligonucleotide substrates CL14 (50-GAAAAAAGACTT
AG-30) was radiolabeled with [g
32P] ATP at their 50-end.
The CP25 complementary strand (50-TAAAAATTTTTC
TAAGTCTTTTTTC-30) was phosphorylated at its 50-end
with unlabeled ATP. CL14/CP25 was annealed as
previously described (18). The suicide cleavage reactions
were carried out by incubating 20nM of the duplex with
an excess of enzyme in 20mM Tris pH 7.5, 0.1mM
Na2EDTA, 10mM MgCl2,5 0 mg/ml acetylated BSA
and 150mM KCl at 23 C in a ﬁnal volume of 50ml
as described by Yang and Champoux (29). A 5ml sample
of the reaction mixture was removed before addition of
the protein and used as the zero time point. At various
time points 5ml aliquots have been removed and the
reaction stopped with 0.5% SDS. After ethanol precipita-
tion samples were resuspended in 5ml of 1mg/ml trypsin
and incubated at 37 C for 30min. Samples have
been analyzed by denaturing urea/polyacrylamide gel
electrophoresis. The percentage of CL1 was determined
by PhosphorImager and ImageQuant software and
normalized on the total amount of radioactivity in
each lane.
Kinetics of religation using oligonucleotide substrate
Twenty nanomolar CL14/CP25, was incubated with an
excess of enzyme for 60min at 23 C followed by 30min
at 37 C in 20mM Tris pH 7.5, 0.1mM Na2EDTA, 10mM
MgCl2,5 0 mg/ml acetylated BSA, and 150mM KCl.
Religation reactions were initiated by adding a 200-fold
molar excess of R11 oligonucleotide (50-AGAAAAATT
TT-30) over the duplex CL14/CP25 in the presence or
absence of 50mM CPT. At 37 C a various time point
5ml aliquots were removed and the reaction stopped
with 0.5% SDS. After ethanol precipitation samples
were resuspended in 5ml of 1mg/ml trypsin and incubated
at 37 C for 30min. Samples were analyzed by denaturing
urea/polyacrylamide gel electrophoresis. The percentage
of religation was determined by PhosphorImager and
ImageQuant software and normalized on the total
amount of radioactivity in each lane.
Cleavage/religation equilibrium
Oligonucleotide CL25 (50-GAAAAAAGACTTAGAAAA
ATTTTTA-30) has been radiolabeled with [g
32P] ATP at
its 50-end. The CP25 complementary strand (50-TAAAAA
TTTTTCTAAGTCTTTTTTC-30) was phosphorylated at
its 50-end with unlabeled ATP. The two strands were
annealed at a 2-fold molar excess of CP25 over CL25. A
ﬁnal concentration of 20nM duplex CL25/CP25 was
incubated with an excess of enzyme at 25 Ci n2 0 m M
Tris pH 7.5, 0.1mM Na2EDTA, 10mM MgCl2,
50mg/ml acetylated BSA, and 50 or 150mM KCl, in the
presence or absence of 50mM CPT. After 30min, the
reaction was stopped by adding 0.5% SDS and digested
with trypsin after ethanol precipitation. Reaction products
were resolved in 16% acrylamide-7M urea gels.
MD
The initial conﬁguration of Top1, in covalent complex
with a 22bp long linear double helix DNA substrate,
has been modeled from the crystal structures 1K4T and
1K4S, (20). The starting positions for residues 201–631
and 708–765 are obtained from the 1K4S crystal structure
and those for residues 632–707 from the 1K4T crystal
structure (since the linker domain is not resolved in the
former), following a mass-weighted ﬁt of backbone atoms
on 1K4S (RMSD between the two structures is 0.7A ˚ after
the ﬁt). Lysine 681 was mutated to alanine using the
rotamer module present in the Chimera package (30).
All the simulations were carried out with the
GROMACS MD package version 3.3.3 (31) modeling
the systems with the AMBER03 all atom force-ﬁeld
(using the porting of AMBER03 force ﬁeld implemented
by Sorin and Pande and available on the ﬀamber project
web site) (32,33). The Top1-DNA complexes were placed
in a rectangular box (93 110 130 A ˚ 3) ﬁlled with TIP3P
water molecules (34), rendered electro neutrals by the
addition of 23 or 24 Na
+ counterions, for the wild type
and for the Lys681Ala mutant respectively, using the
genion program of the GROMACS package, that
replaces solvent molecules by ions at the position with
the most favorable electrostatic potential. The resulting
total systems contained 9456 protein atoms, 1404 DNA
atoms, 23 Na
+ counterions and 40705 water molecules for
the wild type, and 9444 protein atoms, 1404 DNA atoms
24 Na
+ counterions and 40705 water molecules for the
Lys681Ala mutant. Optimization and relaxation of
solvent and ions was initially performed keeping the
protein and DNA atoms constrained to their initial
position with a force constant of 1000kJ/(mol nm), for
2000ps. The systems was then simulated for 15ns in
periodic boundary conditions, at a constant temperature
of 300K using the Berendsen’s method and at a constant
pressure of one bar (35). The pressure was kept constant
(1bar) using the Rahman–Parrinello barostat (36) and
with a 2fs time step. Pressure and temperature coupling
constants are 1 and 0.1ps, respectively. The electrostatic
interactions were taken into account by means of the
Particle Mesh Ewald method (37), using a cut-oﬀ radius
of 1.0nm in real space, while a cut-oﬀ radius of 1.0nm was
chosen for the van der Waals interactions. The lengths of
all bonds were kept constant with the LINCS algorithm
(38). The neighbor list was updated every 10 steps. Direct
hydrogen bonds, root mean square deviations (RMSD)
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analysis were carried out using the GROMACS MD
package version 3.3.3. Figure 8 was created using
the CHIMERA (30) and VMD (39) visualization
packages, respectively; graphs were obtained with the
Grace program (http://plasma-gate.weizmann.ac.il/
Grace/). Secondary structure assignment was performed
by means of the dssp program (40). Electrostatic interac-
tion energy between the linker domain and the DNA or
the other protein domains were calculated performing
reruns of the trajectories with GROMACS, using a cut-
oﬀ of 40A ˚ for the pairs interactions. Multiple sequence
alignment was carried out with the TCOFFEE server (41).
RESULTS AND DISCUSSION
Lys681 is conserved in topoisomerases from
diﬀerent organisms
Gene sequences from topoisomerases IB from diﬀerent
organisms (Cenarchaeum symbiosum, Caenorhabditis
elegans, Xenopus laevis, Cricetulus griseus, Mus musculus,
Rattus norvegicus, Cercopithecus aethiops, Homo sapiens,
Arabidopsis thaliana and Camptotheca acuminata) were
multialigned. The alignment is shown only for the
active site residues (Arg488, Lys532, Arg590, His632,
Tyr723 for the human isoform) and the linker domain
(Figure 1). The ﬁve active site residues are fully conserved
in all the organisms, together with the ﬂanking residues.
In the linker domain only three residues are conserved in
all the organisms: Lys638 (located in the loop connecting
the core subdomain III with the linker domain), Ala668
and Lys681 (located in helices 18 and 19, respectively).
This latter residue is likely to play a crucial role because
of its position almost on the tip of the linker and because
of its positive charge.
Cleavage–religation equilibrium of the wild type and
Lys681Ala mutant
The gel of the native and the Lys681Ala mutant Top1
corresponding to the cleavage–religation equilibrium
Figure 1. Multiple sequence alignment of the topoisomerase IB sequences extracted from C. symbiosum, C. elegans, X. laevis, C. griseus,
M. musculus, R. norvegicus, C. aethiops, H. sapiens, A. thaliana and C. acuminata, respectively. The alignment of the residues in proximity of the
catalytic pentad (Arg488, Lys532, Arg590, His632, Tyr723 for the human isoform) and along the full linker domain is reported. Residues conserved
in all sequences are highlighted by a grey column and evidenced by an asterisk. The residues belonging to the linker domain are underlined.
The mutated residue Lys681 is evidenced by a black triangle.
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substrate CL25 (50-GAAAAAGACTTAGAGAAAAAT
TTT-30)/CP25 at medium (150mM KCl) and low
(50mM KCl) ionic strength, in the absence or presence
of 50mM CPT is reported in Figure 2. At 150mM KCl
and in the absence of CPT (lanes 3 and 7) the intensity of
the band due to the cleavable complex is identical for both
enzymes indicating that in this condition the cleavage/
religation equilibrium is shifted toward religation for
both enzymes. Addition of CPT (lanes 4 and 8) strongly
shifts the equilibrium toward cleavage as indicated by the
increase of the intensity of the band diagnostic of the
presence of the cleavable complex (11). At 50mM KCl
the equilibrium of the Lys681Ala is shifted toward
cleavage when compared to the wild type enzyme
(compare lane 5 with lane 1). Addition of CPT shifts the
equilibrium toward cleavage for the wild type and to a
lower extent for the mutated enzyme where the equilib-
rium is already shifted toward cleavage also in the absence
of CPT (lanes 2 and 6).
Since the cleavage–religation equilibrium constant
(Keq), for a linear DNA substrate is determined by the
ratio of the rate of cleavage (kcl) over the rate of religation
(krl), the increase in the cleavable complex band (Figure 2,
lane 5) indicates that Lys681Ala mutant when compared
to the wild type (Figure 2, lane 1) either cleaves DNA
more eﬃciently or is less eﬃcient in the DNA religation
step. To clarify this point the single steps of the enzyme
catalytic cycle have been analyzed.
Kinetics of cleavage of the wild type and Lys681Ala
mutant
The time course of the cleavage of the wild type and
Lys681Ala mutant has been followed using a suicide
cleavage substrate. In detail, a 50-end radiolabeled
oligonucleotide CL14 (50-GAAAAAAGAC*TT#AG-30)
has been annealed to the CP25 (50-TAAAAATTTTTCT
AAGTCTTTTTTC-30) complementary strand, to produce
a duplex with an 11-base 50-single-strand extension.
The enzyme preferentially cuts at the site indicated by
the arrow and to a lower extent at the site indicated
by the asterisk. In both cases the religation step is
precluded because the AG-30 or TTAG-30 oligonucleotides
are too short to be religated, leaving the enzyme covalently
attached to the 12 or 10 oligonucleotide 30-end.
For a suicide substrate incubated with an excess of wild
type or mutant enzyme, the cleaved DNA fragments have
been resolved in a time course experiment in a denaturing
polyacrylamide gel and are reported in Figure 3A. The
amount of fragment, normalized to the plateau value of
the wild type and Lys681Ala protein, plotted as a function
of time in Figure 3B, shows that both enzymes have an
almost identical cleavage rate (kcl), reaching the plateau
in a comparable time.
Figure 2. Cleavage/religation equilibrium of the full duplex DNA
substrate. Gel electrophoresis of the products coming from the incuba-
tion of the wild type topoisomerase I with the [g-
32P] end-labelled
duplex DNA, shown at the top of the ﬁgure in the absence and
presence of CPT and at diﬀerent KCl concentrations. The arrow at
the DNA sequence indicates the CL1 preferred cleavage site. Lane
1–4 (wild type), lane 5–8 (Lys681Ala). The asterisk indicates the band
corresponding to the CL1 site.
Figure 3. Suicide cleavage experiment for the wild type and Lys681Ala
mutant. (A) Time course of the suicide cleavage reaction carried out
with the substrate described on the top of the ﬁgure. CL1 and CL2
identify the cleaved complexes at the site indicated by the arrow and
the asterisk respectively. Lane C, no protein added. (B) Percentage of
the DNA substrate cleaved plotted at diﬀerent time for the wild type
(black line) and the Lys681Ala mutant (red line).
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Lys681Ala mutant
The DNA religation step has been studied by testing
the ability of both enzymes to religate the oligonucleotide
R11 (50-AGAAAAATTTT-30) added to the cleaved
suicide substrate incubated with an excess of enzyme in
the presence or absence of CPT. Aliquots have been
removed at diﬀerent times, the reaction stopped by
addition of SDS and the products analyzed by poly-
acrylamide gel electrophoresis (Figure 4A). The small per-
centage of religation product formed, plotted as a function
of time in Figure 4B demonstrates that the Lys681Ala
mutant shows a strong decrease in the religation rate
when compared to the wild type protein. The religation
rate decrease is so sharp that addition of CPT does not
have relevant eﬀects, at variance on what observed for the
wild-type protein (Figure 4B).
Structural long range eﬀects of the Lys681Ala mutation
The root mean square deviation (RMSD) of the native
and mutated protein, calculated after a mass-weighted
superposition on the starting structure, is shown in
Figure 5A, as a function of simulation time. The trajectory
of the wild type protein (full black line) shows a higher
deviation from the starting structure as compared to the
trajectory of the Lys681Ala mutant (full red line) (up to
4.5 and 3.0A ˚ for the wild type and Lys681Ala, respec-
tively). However, upon elimination of the linker domain
atoms contribution, the two systems show a comparable
behavior and the amplitude of their deviations is similar.
For both enzymes the RMSD reaches a plateau after
3000ps, and therefore all the following analyses have
been carried out on the last 12000ps (i.e. from 3 to
15ns). The plot of Figure 5A indicates that the linker is
the most deviating domain in both systems, but its contri-
bution to the overall enzyme mobility is higher for the
native protein, as compared to that of the Lys681Ala
mutant.
Figure 5B shows the per residue root mean square
ﬂuctuations (RMSF) of the two enzymes. Similar
ﬂuctuations are observed in the two trajectories, except
Figure 5. (A) RMSD from the starting structure plotted as a function
of simulation time. The RMSD of the native protein and the
Lys681Ala mutant are shown in black and red full lines, respectively.
The RMSD calculated eliminating the linker domain are represented in
black and red dotted lines for the wild type and Lys681Ala mutant,
respectively. (B) Average per-residue RMSF represented as a function
of the residue number for the wild type Top1 protein (full black line)
and Lys681Ala mutant (dashed red line). Subdomain boundaries are
shown as vertical black dot-dashed lines.
Figure 4. Religation experiment for the wild type and Lys681Ala
mutant. (A) Time course of the religation experiment, carried out
with the substrate described on the top of the ﬁgure, between the
R11 substrate and the wild type or Lys681Ala covalent complexes, in
the absence or presence of 50mM CPT. The R11 oligonucleotide is
selectively religated to the CL1. (B) Percentage of the religation
plotted at diﬀerent time for the wild type and Lys681Ala (black and
red lines, respectively), in absence (full line) and presence (dashed line)
of CPT.
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(residues 201–214) where the native protein is more
ﬂuctuating than the Lys681Ala mutant. RMSF of the
DNA bases in the two systems are similar in the scissile
strand (Figure 6A) while the base  1, in the DNA intact
strand, shows an increase of ﬂuctuation (Figure 6B) due to
the loss of the direct interaction between the DNA
backbone and the lateral chain of Lys425, present in the
wild type system (data not shown) (42).
The principal component analysis (PCA) has been
applied to both the mutated and the native enzyme
trajectories, in order to highlight protein concerted
motions. The analysis is based on the diagonalization of
the covariance matrix built from the atomic ﬂuctuations,
after the removal of the translational and rotational
movements, and allows to identify the main 3N directions
along which the majority of the protein motion is deﬁned
(43,44). PCA analysis has been carried out on the 565 Ca
atoms of the protein. Up to 80% of total native enzyme
motion is taken into account by the ﬁrst 15 eigenvectors
(among the 565 that are obtained from the covariance
matrix diagonalization), while 20 eigenvectors are
needed for the Lys681Ala mutant. The displacement
of each Ca along the ﬁrst eigenvector is shown in
Figure 7A. The linker domain is the protein region with
the maximum displacement and no diﬀerences along
this direction are found between mutated and wild type
proteins. Small diﬀerences are observed in the N-terminal
and C-terminal regions of the core domain that show a
slightly larger and a slightly smaller displacements respec-
tively in the wild type than in the mutant enzyme.
Figure 7B shows the Ca displacements along the second
eigenvector. The main diﬀerence is found for the linker
domain that shows a much higher displacement in the
native enzyme than the mutated protein, where this
region has a displacement of the same magnitude as the
other domains. Some diﬀerences are also observed in the
C-terminal domain that is more mobile in the wild type,
while the core subdomains show overall comparable
displacements, with the exception of helix 5 region
(residues 303–319) in core subdomain II, one of the so
called ‘nose cone’ helices, that is more mobile in the
mutated enzyme. The loss of linker domain mobility can
be appreciated looking at Figures 8B (native enzyme) and
8C (Lys681Ala mutant), where 10 projections of the
protein motions along the second eigenvector are shown
with diﬀerent colors. The principal component analysis
indicates that the regions more altered in their dynamics,
as a result of the single mutation, are those contacting the
DNA scissile strand, which therefore play a role during
the DNA relaxation process. In particular, even though
helix 5 has comparable average per residue RMSF in the
Figure 6. Average per-base RMSF as a function of the base number
for the DNA in the wild type (full black line) and in the Lys681Ala
mutant (dashed red line) Top1 DNA system. (A) scissile DNA strand.
(B) Intact DNA strand.
Figure 7. Displacements of each Ca atom along the ﬁrst two
eigenvectors are represented in black continuous lines and dashed
red lines for the wild type and Lys681Ala mutant, respectively.
(A) Displacements along the ﬁrst eigenvector. (B) Displacements
along the second eigenvector.
Nucleic Acids Research, 2009,Vol.37, No. 20 6855two systems (Figure 5B), its ﬂuctuations in the mutant are
lower along the ﬁrst eigenvector and higher along the sec-
ond eigenvector, as can be well appreciated looking
at motion projections along the second eigenvector
(Figure 8).
Electrostatic long range perturbation
Even though it is well known that several single residue
mutations, such as Ala653Pro, Thr718Ala, Glu418Lys,
and Thr729Ala, have long range eﬀects on the complex
topoisomerase machinery (15,23,25,45), this is the ﬁrst
example in which the causes of the interdomain commu-
nication are not easily attributable to a direct eﬀect, such
as the alteration of direct or water mediated hydrogen
bonds. Moreover secondary structure assignment shows
that mutation of residue 681 from lysine to alanine does
not cause alterations in the linker domain secondary struc-
ture (Figure 10 in the Supplementary Data) and the main
chain conformation of the mutated residue does not
signiﬁcantly change in relation with the neighbor
residues, when compared to the wild type protein.
We have therefore investigated the alteration in the
protein electrostatic ﬁeld, caused by the elimination, in
the mutant, of the positively charged residue. The
average electrostatic interaction energy between the
linker and the DNA, calculated for all the trajectories is
about  10200kJ/mol in the wild type enzyme, while it
decreases to  8600kJ/mol in the Lys681Ala mutant
(Figure 11 in the Supplementary Data). The elimination
of the single highly conserved positive charge of Lys681,
therefore, produce a reduction of 16% of the linker-DNA
interaction energy. The electrostatic interaction between
the linker and any other protein domains, on the
contrary, does not show any signiﬁcant diﬀerence
between the native and the mutated enzyme.
Perturbation of active site architecture
The structure of the catalytic pentad is very stable since it
maintains the same deﬁnite geometrical arrangement over
the trajectory in both simulations. This result can be
appreciated overlapping the active site Ca atoms of the
last snapshots of the two simulations. The Ca atoms
RMSD of these two conﬁgurations is 0.50A ˚ and the
largest deviation from the crystallographic structure
from any conﬁguration sampled during the trajectories is
0.97 and 0.91A ˚ for the native and mutated simulation
respectively.
An interesting diﬀerence is observed when comparing
the distance between the O50 oxygen atom on the
guanosine in position +1 on the cleaved strand and the
highly conserved Lys532 Ne atom (Figure 1). This
distance is reported as a function of simulation time for
the native and mutant enzyme in Figure 9. After the
thermalization and equilibration phases, the two systems
are in quite diﬀerent conformations, the amino group of
the lysine residue in the mutant being closer to the
nucleotide by about 2.5A ˚ when compared to the wild
type enzyme. During the trajectory the two enzymes
behave in a completely diﬀerent way: after 5ns Lys532
in the native enzyme starts to get closer to the O50
Figure 8. Three-dimensional structure of the Top1-DNA binary
complex. The protein subdomain I, subdomain II, subdomain III are
rappresented in blue, yellow and red respectively, the linker in green
and C-terminal in cyan. The lateral chain of the mutated Lys681 residue
is represented in ball and stick and evidenced by a line. Nose cone helix 5
is also evidenced by a line (A). Representation of ten projections, in dif-
ferent colors, of the MD motions along the second eigenvector for the
wild-type protein (B) and Lys681Ala mutant (C).
6856 Nucleic Acids Research, 2009,Vol.37, No. 20guanosine (reaching an average distance of 6A ˚ ), while the
opposite occurs in Lys681Ala where the same residue
moves away from the O50 guanosine group, (reaching an
average distance of 8.5A ˚ ). These last distance values are
reached after 7.5 of simulation time and fully maintained
afterwards. Lys532 has been proposed to act as a general
acid catalyst in the cleavage phase, donating a proton to
the leaving strand nucleotide, and as a general base
catalyst in the religation step, accepting a proton from
the same nucleotide (46–48). This residue has therefore a
crucial role in the catalytic reaction. The longer average
distance between the O50 atom of the DNA guanosine +1
and Lys532 lateral chain, observed in the mutant system,
constitutes a relevant obstacle to the proton transfer in the
religation phase and provides a molecular explanation for
the altered religation rate, experimentally observed for the
Lys681Ala mutant.
CONCLUSIONS
The linker domain has a crucial role in the control of the
catalytic cycle of human topoisomerase I. Such a ﬁnding
was initially proposed by Champoux and co-workers ten
years ago, when they demonstrated that reconstitution of
an enzyme, made by the core domain plus a COOH-
terminal fragment containing the complete linker region,
renders the linker non-functional and modulates the
religation rate (13). Since then several papers appeared
showing through experimental and computation
approaches the interdependence between the linker and
the active site region (14,23,26).
In this work we show how mutation of a residue
Lys681, located on the tip of the linker domain and that
apparently should not have any role in the functional
properties of the enzyme, dramatically reduces the
religation rate. The mutant is characterized by an altered
dynamics of the linker and a varied linker-DNA interac-
tion energy, correlated with a lengthening of the +1 base
O50-Lys532 distance and thus providing an atomic
explanation for the reduced religation rate. These results
demonstrate the crucial role played by this domain and the
occurrence of a long range communication between the
linker and the active site region.
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Supplementary Data are available at NAR Online.
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